Product Details
Phesgo 600mg/600mg/10ml#
Pertuzumab; Trastuzumab600mg/10ml; 600mg/10ml
Injection
ROA
Subcutaneous
Applicant Name
Roche Products Limited
NRN
A6-100047
Status
Active
Composition
ATC Code
L01XY02
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 vial
Product Description
Phesgo 600mg/600mg/10ml Pertuzumab and Trastuzumab Active Substances . Pertuzumab 600mg , trastuzumab 600mg Excipients Human hyaluronidase (rHuPH20) (produced by recombinant DNA technology using CHO [Chinese hamster ovary] cells) -, L-histidine hydrochloride monohydrate 36.1mg , L-histidine 4.40mg, a,a-trehalose dehydrate 397mg , sucrose 342mg , polysorbate 20* 4.00mg, L-methionine 14.9mg , water for injection QS to 10ml . A6-100047 Vaccines & Biologicals Biologics Imported Products 1 11/10/2021 Roche Products Limited, 8th Floor, Roche Office 21 Mobolaji Bank Anthony Way, Etiebet's Place, Ikeja. Lagos 8056292219 angela.essien@roche.com F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, Switzerland
Manufacturer Name
F.Hoffmann La Roche Limited
Manufacturer Country
SWITZERLAND
Approval Date
2022-11-02
Expiry Date
2027-11-01